Skip to content

Health

Britain Has Chosen Big Pharma Over the NHS

Britain has accepted a trade linked medicines pricing reset that makes the NHS pay more. NICE’s new chief executive has warned that paying more to satisfy Trump style demands is a huge backwards step because higher drug spend means higher taxes or NHS cuts. This analysis explains what the government agreed, why the policy is fracturing, and how the NHS cost can be estimated.

How Tumours Use the Nervous System: Cancer Neuroscience, Drug Repurposing, and the Evidence Big Pharma Ignores

Cancer neuroscience shows that tumours do not just sit in the body. They recruit nerves, form synapses, steal mitochondria and tap into the stress system to grow and spread. Some of the most promising ways to interfere with that wiring involve cheap drugs we already have. The science is glamorous. The problem is simple. No one can make enough money from the obvious experiments.

When Tumors Hijack the Nervous System

For decades, cancer was understood as a disease of rogue cells, growing uncontrollably, feeding themselves through blood vessels and oxygen supplies. But a wave of discoveries is reshaping that picture, and with it, the future of treatment. Scientists now argue that tumors are not only fed by blood, but also by nerves. They are discovering […]